Skip to main content


Fig. 3 | Virology Journal

Fig. 3

From: Arsenic trioxide inhibits EBV reactivation and promotes cell death in EBV-positive lymphoma cells

Fig. 3

ATO inhibited cell viability in a dose- and time-dependent manner. a EBV latency type I (Akata), type II (Cl13) and type III (JY) cells were treated with ATO for 3 days at the indicated concentrations (0.5 nM – 10 nM) and cell viability was analyzed using a trypan blue method. *, p < 0.05 vs. no treatment (NT). b The time course analysis of cell viability in response to 2 nM of ATO in EBV-positive cells. c The dose- and time-course analysis of cell viability after treatment with ATO in Farage cells. d The combination of ATO (10 nM) and ganciclovir (45 μM) synergistically decreased cell viability on day 3 in EBV-positive cells. *, p < 0.05 vs. NT

Back to article page